RhumbLine Advisers
IMUX icon

RhumbLine Advisers’s Immunic IMUX Stock Holding History

RhumbLine Advisers’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,212
Closed -$250K – 3165
2022
Q1 		$250K Buy
2,212
+518
+31% +$60K ﹤0.01% 2698
2021
Q4 		$162K Buy
1,694
+162
+11% +$14.6K ﹤0.01% 2879
2021
Q3 		$136K Buy
1,532
+116
+8% +$11.4K ﹤0.01% 2963
2021
Q2 		$174K Buy
+1,416
New +$196K ﹤0.01% 2932
2019
Q2 		– Sell
-90
Closed -$7K – 2989
2019
Q1 		$7K Sell
90
-4
-4% -$351 ﹤0.01% 2939
2018
Q4 		$7K Buy
94
+30
+47% +$3.51K ﹤0.01% 2974
2018
Q3 		$7K Sell
64
-3
-4% -$7.83K ﹤0.01% 2918
2018
Q2 		$183K Buy
+67
New +$155K ﹤0.01% 2756
2017
Q2 		– Sell
-64
Closed -$103K – 2936
2017
Q1 		$103K Buy
64
+3
+5% +$5.49K ﹤0.01% 2775
2016
Q4 		$107K Sell
61
-16
-21% -$35K ﹤0.01% 2788
2016
Q3 		$188K Buy
77
+1
+1% +$2.47K ﹤0.01% 2700
2016
Q2 		$188K Buy
76
+27
+55% +$88.7K ﹤0.01% 2770
2016
Q1 		$177K Buy
49
+4
+9% +$13.9K ﹤0.01% 2769
2015
Q4 		$208K Buy
45
+9
+25% +$29.4K ﹤0.01% 2776
2015
Q3 		$57K Buy
36
+2
+6% +$10K ﹤0.01% 2988
2015
Q2 		$289K Buy
+34
New +$324K ﹤0.01% 2680

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

RhumbLine Advisers's IMUX Position: Q2 2022 in Review

RhumbLine Advisers sold out of Immunic (IMUX) in Q2 2022, closing a stake of 2,212 shares — an estimated $250K sold.

RhumbLine Advisers first reported a position in IMUX in Q2 2015 and held it in 16 quarters. The position peaked at $289K in Q2 2015. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • RhumbLine Advisers reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 2,212 Immunic shares in Q2 2022, an estimated $250K.
  • RhumbLine Advisers first reported a position in Immunic in Q2 2015 and held it in 16 quarters.
  • RhumbLine Advisers's Immunic position peaked at $289K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.